NuVasive Inc. (NSDQ:NUVA) added 3 new members to its European operations, the company announced this week.

Frank Middeke was appointed managing director of Germany, Austria, & Switzerland for the medical device company. He was recently the National Sales Director for DePuy Orthopedics‘s Joint Reconstruction Unit in Germany.

Christoph Hoemberg will become the director of sales in Germany. Most recently, he served as regional sales manager for Johnson & Johnson (NYSE:JNJ) subsidiary, DePuy Synthes.

Constantino Barros was added from Medtronic (NYSE:MDT), where he served as country manager in Spain. He will take over as country director in the same country, for NuVasive.

“I am exceptionally pleased to welcome Frank, Christoph, and Tino to the NuVasive Family. I look forward to their contributions as we collaborate to strengthen the NuVasive footprint in Europe, particularly in the DACH region. Based on the quality of the EMEA team that we now have in place, I am confident that we can work to drive toward market leadership in an area with considerable opportunity,” EMEA senior VP Paul Kosters said in prepared remarks.

San Diego-based NuVasive trumped Wall Street expectations in this year’s 3rd quarter, built on the back of tripling its profits that quarter. The company posted profits of $7.5 million, or 16¢ per share, on sales of $169.2 million for the 3 months ended Sept. 30, for a bottom-line gain of 219.1% on sales growth of 14.0%.

NUVA stock was trading at $32.46, up 1.5% today, as of 12:40 p.m.